The precision medicine firm Tempus AI has announced a definitive agreement to acquire Personalis Biotech for approximately $1.5 billion. With the Personalis …
Global biopharmaceutical leader Bristol Myers Squibb (BMS) has announced an expanded collaboration with technology giant NVIDIA. The Bristol Myers Squibb and NVIDIA …
The U.S. Food and Drug Administration (FDA) has approved Merck’s cholesterol pill, Lipfendra (enlicitide). Lipfendra is the first-ever FDA-approved oral PCSK9 inhibitor. …
The world’s biggest pharmaceutical company, Eli Lilly, has announced a definitive agreement to buy the clinical-stage biopharmaceutical firm AtaiBeckley. The deal is …
Sun Pharmaceutical Industries has secured marketing approval for its generic semaglutide medicine from the South African Health Products Regulatory Authority (SAHPRA). With …
The cyclosporiasis outbreak in USA continues to grow as the Centers for Disease Control and Prevention (CDC) announced that 1,645 domestically acquired …
An urgent Mt Ossa Australian Spring Water recall has been issued across select regions of the country. The Tasmanian Mountain Waters Exp …
In a milestone achievement for oncology, the biopharma giant GSK’s Jemperli cancer drug trial has met positive interim Phase II results from …
The University of Oxford has officially launched the world’s first Phase I clinical trial of a vaccine specifically targeting the Bundibugyo ebolavirus. …
The Grattan Institute has released a landmark report, Future Pharmacy: A Better Deal for Patients and Taxpayers. This report on Australian Pharmacy …
A crusted scabies infection, a highly contagious form of scabies, has spread in Glangwili Hospital in Carmarthen, Wales, triggering an immediate public …
The U.S. Food and Drug Administration (FDA) has announced a major, nationwide Class II recall involving more than 2.53 million prescription eye …
The precision medicine firm Tempus AI has announced a definitive agreement to acquire Personalis Biotech for approximately $1.5 billion. With
Global biopharmaceutical leader Bristol Myers Squibb (BMS) has announced an expanded collaboration with technology giant NVIDIA. The Bristol Myers Squibb
The U.S. Food and Drug Administration (FDA) has approved Merck’s cholesterol pill, Lipfendra (enlicitide). Lipfendra is the first-ever FDA-approved oral
The world’s biggest pharmaceutical company, Eli Lilly, has announced a definitive agreement to buy the clinical-stage biopharmaceutical firm AtaiBeckley. The
Sun Pharmaceutical Industries has secured marketing approval for its generic semaglutide medicine from the South African Health Products Regulatory Authority
The cyclosporiasis outbreak in USA continues to grow as the Centers for Disease Control and Prevention (CDC) announced that 1,645
An urgent Mt Ossa Australian Spring Water recall has been issued across select regions of the country. The Tasmanian Mountain
In a milestone achievement for oncology, the biopharma giant GSK’s Jemperli cancer drug trial has met positive interim Phase II
The University of Oxford has officially launched the world’s first Phase I clinical trial of a vaccine specifically targeting the
The Grattan Institute has released a landmark report, Future Pharmacy: A Better Deal for Patients and Taxpayers. This report on
A crusted scabies infection, a highly contagious form of scabies, has spread in Glangwili Hospital in Carmarthen, Wales, triggering an
The U.S. Food and Drug Administration (FDA) has announced a major, nationwide Class II recall involving more than 2.53 million
